Structures by: Armstrong D.
Total: 13
C19H16F6N2O3
C19H16F6N2O3
Journal of medicinal chemistry (2020)
a=9.449(1)Å b=19.3720(18)Å c=21.3178(19)Å
α=90° β=97.644(7)° γ=90°
C22H26N2O3
C22H26N2O3
Journal of medicinal chemistry (2020)
a=21.4182(5)Å b=22.3478(5)Å c=9.3093(2)Å
α=90° β=90° γ=90°
C19H40LiN3Zn
C19H40LiN3Zn
New Journal of Chemistry (2013) 37, 2 494
a=10.6264(6)Å b=14.7725(7)Å c=14.6357(10)Å
α=90.00° β=104.793(7)° γ=90.00°
C17H36LiN3Zn
C17H36LiN3Zn
New Journal of Chemistry (2013) 37, 2 494
a=10.3386(6)Å b=10.3386(6)Å c=37.798(2)Å
α=90.00° β=90.00° γ=90.00°
C20H30BiBr
C20H30BiBr
Dalton Trans. (2017)
a=25.362(2)Å b=6.4647(5)Å c=21.7366(16)Å
α=90° β=93.377(3)° γ=90°
C30H38N2Zn
C30H38N2Zn
Dalton Trans. (2017)
a=10.7437(4)Å b=10.9461(5)Å c=11.8493(5)Å
α=86.964(2)° β=66.110(2)° γ=78.578(2)°
C30H38N2Zn
C30H38N2Zn
Dalton Trans. (2017)
a=10.5819(10)Å b=11.0816(10)Å c=11.7087(11)Å
α=87.754(3)° β=66.311(3)° γ=78.315(3)°
C28H48AuP,C6H6
C28H48AuP,C6H6
Dalton Trans. (2017)
a=31.365(3)Å b=11.1433(10)Å c=20.942(2)Å
α=90° β=123.019(2)° γ=90°
C28H30AuP
C28H30AuP
Dalton Trans. (2017)
a=10.1522(13)Å b=10.8738(14)Å c=10.8790(13)Å
α=84.635(4)° β=73.822(4)° γ=78.439(4)°
C24H35BN8OPd
C24H35BN8OPd
Dalton transactions (Cambridge, England : 2003) (2017) 46, 12 4004-4008
a=7.9636(7)Å b=12.4983(12)Å c=13.5112(12)Å
α=89.710(2)° β=87.268(2)° γ=81.870(2)°
C18H31BN6Pd
C18H31BN6Pd
Dalton transactions (Cambridge, England : 2003) (2017) 46, 12 4004-4008
a=16.3066(9)Å b=9.8567(6)Å c=25.2093(14)Å
α=90.00° β=90.00° γ=90.00°
C28H61N4NaOZn
C28H61N4NaOZn
Chem. Commun. (2012) 48, 1541
a=17.3607(4)Å b=13.0692(4)Å c=28.9589(8)Å
α=90.00° β=98.010(1)° γ=90.00°
C68H110N6Na2O2Zn2
C68H110N6Na2O2Zn2
Chem. Commun. (2012) 48, 1541
a=11.9774(7)Å b=15.1883(13)Å c=20.8913(16)Å
α=102.420(7)° β=105.102(6)° γ=91.831(6)°